Loading
Life sciences · Journal article
American Heart Journal · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Obesity, type 2 diabetes, MASH, and cardiovascular disease share dysregulated lipid handling in metabolic tissues. The lipid mediator 20-HETE is implicated in vascular dysfunction, hypertension, and cardiovascular disease through GPR75 signaling, while human loss-of-function variants in GPR75 protect against obesity. However, the adipocyte mechanism linking 20-HETE/GPR75 signaling to lipid accumulation remains incompletely defined. We asked whether FATP1/SLC27A1, an adipocyte-enriched fatty-acid transporter, mediates the downstream uptake step in mature adipocytes. Methods Murine 3T3-L1 cells were differentiated into mature adipocytes over 10 days. Intracellular Ca²⁺ flux was measured using FLIPR Calcium 6 dye after stimulation with 20-HETE (10 nM) or vehicle. Fatty- acid uptake was quantified using a fluorescence-based uptake assay. To assess transporter involvement, mature adipocytes were pretreated with FATP1-IN-1 (FATP1 inhibitor) or sulfosuccinimidyl oleate (SSO, CD36 inhibitor) before 20-HETE stimulation. Results 20-HETE induced a rapid Ca²⁺ transient in mature Day 10 adipocytes, followed within minutes by increased fatty-acid uptake; both responses were minimal in Day 0 preadipocytes. FATP1-IN-1 did not suppress the proximal Ca²⁺ response but abolished 20-HETE-induced fatty-acid uptake, implicating FATP1 as the dominant transporter mediating the acute uptake step. In contrast, SSO did not suppress peak uptake and increased early uptake/AUC, suggesting that CD36 is not the primary transporter for this response and may play a modulatory role. Conclusions These findings identify FATP1 as the adipocyte transporter arm of a rapid peripheral 20-HETE/GPR75/Ca²⁺-associated lipid-uptake pathway. We propose a novel feed-forward adipocytelipid-burden model in which lipid overload increases 20-HETE/GPR75 signaling, promoting FATP1-dependent fatty-acid uptake and further metabolic dysfunction. Is this an encore abstract? No